Biotech · Private company · Ann Arbor, MI, US
Mitovation, Inc
Track this companyFree. Adds Mitovation, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- LUTICIA - Light Utilization COX-Inhibitory Device)Reperfusion InjuryClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Light Utilization COX-Inhibitory Device Therapy for Infant Cardiac Arrest (LUTICA Study). The LUCID Device is Used in the Treatment of Ischemic Brain Reperfusion Injury Caused by Cardiac Arrest in Pediatric Patients.NA · NOT_YET_RECRUITING · started Jul 15, 2026ClinicalTrials.gov NCT07556939 · fetched Nov 12, 2026
NIH awards2
- Development and Testing of LUCID: A Therapeutic Device for Brain Injury Following Infant Cardiac ArrestFiscal year 2026 · $1.5MNIH RePORTER 4U44NS125160-03 · fetched Nov 12, 2026
- Development and Testing of LUCID: A Therapeutic Device for Brain Injury Following Infant Cardiac ArrestFiscal year 2024 · $99.4KNIH RePORTER 3U44NS125160-02S1 · fetched Nov 12, 2026